Trial Profile
Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 10 May 2011
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Haloperidol
- Indications Psychotic disorders
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 10 May 2011 New trial record